@irishamerica #curamslainte50

A W A R D S R E C E P T I O N � C O - H O S T E D B Y � O C T O B E R 5 , 2 0 1 6

2016 Keynote Speaker

D R . B A R B A R A M U R P H Y

Mount Sinai Health System

Chair, Samuel Bronfman Department of Medicine

Murray M. Rosenberg Professor of Medicine

Dean, Clinical Integration and Population

Management at the Icahn School of Medicine

A B O U T T H E I R I S H A M E R I C A

H E A LT H C A R E & L I F E S C I E N C E S 5 0

The annual Irish America Healthcare & Life Sciences 50 list

recognizes the excellence, performance, and extraordinary

contributions of Irish-American leaders in fields including

medical care, pharmaceuticals, biotechnology, medical devices,

research and development, and life sciences venture capital.

@irishamerica #curamslainte50

L I Z M C K E E A N D E R S O N

Revolution Medicines

Independent Board Director

Trustee of the Wistar Institute

Principal of PureSight Advisory LLC

D R . C H R I S T I N A B R E N N A N

NorthWell Health

Vice President of Clinical Research

D R . W I L L I A M C A M P B E L L

Recipient of the 2015 Nobel Prize in Medicine

Associate Fellow, RISE Program at Drew University

D R . B J C A S E Y

Weill Cornell Medical College

Professor of Developmental Psychobiology

and Director of the Sackler Institute

D R . M I C H E L E C L E A R Y

Bristol-Myers Squibb

Vice President and Head of Clinical

Translational Technologies & Operations

CORA CREED

VP Digital Supply Chain Network,

Universal Music Group

D R . PAT R I C K C O N W AY

Centers for Medicare & Medicaid Services

Deputy Administrator for Innovation & Quality

and Chief Medical Officer

D R . T O B Y C O S G R O V E

Cleveland Clinic

President and CEO

D R . W I L L L I A M C R O W L E Y, J R .

Harvard Medical School

Professor of Medicine and Director,

Harvard Reproductive Endocrine Sciences Center

D R . D A N I E L C U R R A N

Takeda Pharmaceuticals

Senior Vice President and

Head of the Center for External Innovation

M A U R A D A LY

Doctors Without Borders

Midwife

D R . J O A N N E D O N O VA N

Catabasis Pharmaceuticals

Chief Medical Officer

B R I A N D O U G H E R T Y

AstraZeneca Pharmaceuticals

Director of Translational Genomics Oncology

M I C H A E L D O W L I N G

NorthWell Health

President and CEO

B I L L D O Y L E

Novocure

Executive Chair

D R . G A R R E T A . F I T Z G E R A L D

University of Pennsylvania

Chair of the Department of Pharmacology and Director,

Institute for Translational Medicine & Therapeutics

D R . K E I T H F L A H E R T Y

Massachusetts General Hospital

Cancer Center

Director, Henri and Belinda Termeer Center for

Targeted Therapies, and Professor of Medicine

at Harvard Medical School

C R A I G F L A N A G A N

Sanofi Pharmaceuticals

Global Head of Field Excellence & Capabilities,

Diabetes and Cardiovascular Business Unit

SPECIAL THANKS TO OUR CO-HOST

AND TO OUR SPONSORS

Mutual of America w The Coca-Cola Company w House of Waterford Crystal

Icahn School of Management at Mount Sinai w Tourism Ireland

UCD Michael Smurfit Graduate Business School w The American Ireland Fund

CIE Tours International w 1-800-Flowers.com

A B O U T I C O N P L C

ICON plc is a global provider of drug development solutions and services to the

pharmaceutical, biotechnology and medical device industries and is one of

Ireland’s most successful indigenous companies. The company specializes in the

strategic development, management, and analysis of programs that support

clinical development – from compound selection to Phase I-IV clinical studies.

ICON currently employs over 12,300 employees in 37 countries worldwide.

D R . J A M E S D . G R I F F I N

Dana Farber Cancer Institute

Chair of the Department of Medical Oncology

Professor of Medicine, Harvard Medical School

D R . K E V I N H O R G A N

AstraZeneca

Global Medical Lead

S I S T E R C A R O L K E E H A N

Catholic Health Association of the U.S.

President and CEO

D R . N E I L K E L L E H E R

Northwestern University

Walter & Elizabeth Mary Glass Professor

Professor of Chemistry and Molecular Biosciences

at the Feinstein School of Medicine

Director, Proteomics Center of Excellence

D R . D E B O R A H K I L PAT R I C K

Evidation Health

CEO

J U S T I N M C C A R T H Y

Pfizer

Senior Vice President

Global Policy & International Affairs

A M Y M C D O N O U G H

FitBit

Vice President of Corporate Wellness

E R I N M C D O N O U G H

Brigham and Women’s Hospital

Senior Vice President and

Chief Communications Officer

D R . G E R A L D I N E M C G I N T Y

Weill Cornell Medical College

Assistant Professor of Radiology

Assistant Attending Radiologist

at New York Presbyterian Hospital

Chair of the American College

of Radiology Commission on Economics

D R . D O N N I E M C G R AT H

Bristol-Myers Squibb

Vice President and Head of

Global Search & Evaluation,

Worldwide Pharmaceutical Finance

M I C H A E L P. M C L O U G H L I N

Johns Hopkins Applied Physics Lab

Chief Engineer, Research and

Exploratory Development

A N N M E E K E R - O ’ C O N N E L L

Johnson & Johnson

Global Head, Risk Management &

External Engagement, Bioresearch

Quality & Compliance

D R . M I C H A E L P. M U L L E N

Mount Sinai Hospital

Director, Institute for Advanced Medicine

Professor of Medicine and Infectious Diseases

D R . J O S E P H M U LV E H I L L

Concierge Medicine

Physician

D O R E M U R P H Y

Pager

Vice President of Marketing

D R . M A R T I N J . M U R P H Y

AlphaMed Consulting

Chairman and CEO

D R . J O H N F. N E Y L A N I I I

Keryx Biopharmaceuticals

Senior Vice President and

Chief Medical Officer

D R . S T E P H E N J . O ’ B R I E N

Hospital for Special Surgery

Attending Orthopedic Surgeon

D R . D AV I D O ’ C O N N O R

University of Wisconsin

Professor of Pathology

and Laboratory Medicine

School of Public Health

D R . O W E N A . O ’ C O N N O R

Columbia University Medical Center

Professor of Medicine and Experimental Therapeutics

Director of the Center for Lymphoid Malignancies

Co-Director, Lymphoid Development & Malignancy Program

R O R Y O ’ C O N N O R

Pfizer Innovative Pharmaceuticals

Senior Vice President and

Head of Global Medical Affairs

D A N I E L O ’ D AY

Roche

CEO, Pharmaceuticals Division

M A R G A R E T O ’ K A N E

National Committee for Quality Assurance

President

H U G H O ’ N E I L L

Mallinckrodt

Senior Vice President and President

Autoimmune and Rare Diseases

D R . E I L E E N O ’ R E I L LY

Memorial Sloan Kettering

Associate Member

Gastrointestinal Oncology Service

L O R I R E I L LY

PhRMA

Executive Vice President

Policy, Research & Membership

D R . M U R E D A C H R E I L LY

Columbia University Medical Center

Director Designate

Herbert Florence Irving Professor of Medicine

Irving Institute for Clinical & Translational Research

D R . F R A N K R E Y N O L D S

PixarBio Corporation

Chairman of the Board

CEO, CFO, CSO, and Co-Founder

O R L A I T H S TA U N T O N

Rory Staunton Foundation

Founder

D R . J A M E S P. S U L L I VA N

AbbVie

Vice President, Discovery

J O H N S U L L I VA N

TransMedics

Vice President of Engineering

D R . R U T H S U L L I VA N

Autism Society of America

Co-founder

D R . J A M E S W AT S O N

Cold Spring Harbor Laboratory

Chancellor Emeritus and Nobel Laureate

A B O U T I R I S H A M E R I C A M A G A Z I N E

Since its inception in October 1985, Irish America has become a

powerful vehicle for expression on a range of political, economic,

social, and cultural themes that are of paramount importance to the

Irish in the United States. It has helped re-establish the Irish ethnic

identity in the U.S. (34.7 million according to the last U.S. census) and

highlights the best political and business leaders, organizations,

artists, writers, and community figures among the Irish in America.

@irishamerica #curamslainte50